| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.22 | 0.4 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.4 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.4 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.4 |